ADIAL PHARMACEUTICALS INC ADIL
COM NEW · Common Stock · CUSIP 00688A205
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersCharlottesville, VA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2023 | 11 |
| Q4 2023 | 17 |
| Q1 2024 | 16 |
| Q2 2024 | 16 |
| Q3 2024 | 12 |
| Q4 2024 | 14 |
| Q1 2025 | 13 |
| Q2 2025 | 17 |
| Q3 2025 | 16 |
| Q4 2025 | 23 |
| Q1 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 7 | 7 |
| Q3 2024 | 4 | 7 |
| Q4 2024 | 6 | 4 |
| Q1 2025 | 6 | 4 |
| Q2 2025 | 7 | 3 |
| Q3 2025 | 8 | 6 |
| Q4 2025 | 12 | 5 |
| Q1 2026 | 0 | 22 |
Biggest buyers
| None |
Biggest sellers
| ARMISTICE CAPITAL, LLC | Sold out | -2.6m |
| CITADEL ADVISORS LLC | Sold out | -219.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -155.7k |
| JANE STREET GROUP, LLC | Sold out | -121.8k |
| NORTHERN TRUST CORP | Sold out | -66.0k |
| Virtu Financial LLC | Sold out | -63.8k |
| XTX Topco Ltd | Sold out | -52.1k |
| Manchester Capital Management LLC | Sold out | -48.1k |
| BlackRock, Inc. | Sold out | -27.8k |
| StoneX Group Inc. | Sold out | -19.5k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| ARMISTICE CAPITAL, LLC 13G · institution new · filed 2026-02-18 | 10.0% |
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2026.
Holders, Q1 2026
| Manager | Shares | Change |
|---|